Other studies of HNSCC/ESCC also reported that a lower concentration of CSTB increased the risks of lymph node metastasis (35, 59) and local tumor recurrence (35) and may thus result in a shorter DFS (35, 86). Here, CSTB is linked to metastatic malignant neoplasm in the lymph nodes.